Heron Therapeutics Inc (HRTX)

R&D to Revenue

7.17%

Quarterly · Period ending:

HRTX logo

HRTX R&D to Revenue

Latest reported7.17%
HRTX Quarterly R&D/Revenue (0.00% → 7.17%)
High-resolution chart · PNG

HRTX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
154.4%
141.9543%
172.498%
89.1415%
97.8818%
19.2046%
20.5607%
20.4082%
21.2766%
23.913%
23.0769%
20.4082%
23.5294%
21.7391%
21.7391%
21.9512%
20%
18%
15.7895%
22.7273%
18.5185%
17.3077%
37.5%
29.0323%
21.2766%
17.6471%
50%
50%
43.1818%
25.4902%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.